Title:
AZAHETEROARYL COMPOUND AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/032004
Kind Code:
A9
Abstract:
Disclosed in the present invention are an azaheteroaryl compound, a pharmaceutically acceptable salt thereof, and a solvate thereof. The present invention also provides a method for preparing said compound, a composition containing said compound, and a use of said compound in the preparation of a drug for treating a disease or disorder related to the mechanism of action of an EED protein and/or a PRC2 protein complex. (Formula 1)
More Like This:
| WO/2021/082714 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE |
| JP2024510606 | KRAS G12D inhibitor |
| WO/2024/008178 | KRAS G12D INHIBITOR AND APPLICATION THEREOF IN MEDICINE |
Inventors:
MA SHICHAO (CN)
ZHANG ZHONGGUO (CN)
ZHANG SONG (CN)
YUAN WENJIA (CN)
ZHANG ZHONGGUO (CN)
ZHANG SONG (CN)
YUAN WENJIA (CN)
Application Number:
PCT/CN2020/109232
Publication Date:
March 25, 2021
Filing Date:
August 14, 2020
Export Citation:
Assignee:
SHANGHAI BLUERAY BIOPHARMA CO LTD (CN)
International Classes:
C07D519/00; A61K31/519; A61P35/00; A61P35/02; C07D239/30; C07D307/93; C07D487/04
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: